Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+103.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+103.3%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
8.4x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 840.86% |
| Q2 2025 | 14.81% |
| Q1 2025 | -95.51% |
| Q4 2024 | 830.93% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 100.00% |
| Q2 2023 | 40.73% |
| Q1 2023 | 26.29% |
| Q4 2022 | 0.00% |
| Q3 2022 | 100.00% |
| Q2 2022 | -9.74% |
| Q1 2022 | 9.00% |
| Q4 2021 | -48.49% |
| Q3 2021 | 26.18% |
| Q2 2021 | -14703.23% |
| Q1 2021 | 100.52% |
| Q4 2020 | 10.10% |
| Q3 2020 | -1876.10% |
| Q2 2020 | 104.74% |
| Q1 2020 | -1167.59% |
| Q4 2019 | 5.94% |
| Q3 2019 | -14.13% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 100.00% |
| Q4 2017 | -17.14% |
| Q3 2017 | 0.00% |